• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 9, 2023

    3/9/23 8:00:50 AM ET
    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Aerospace
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACHR alert in real time by email

    Companies Reporting Before The Bell

    • Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.

    • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.22 per share on revenue of $502.24 million.

    • Navios Maritime Hldgs (NYSE:NM) is expected to report earnings for its fourth quarter.

    • Fulcrum Therapeutics (NASDAQ:FULC) is projected to report quarterly loss at $0.49 per share on revenue of $1.65 million.

    • Acorda Therapeutics (NASDAQ:ACOR) is estimated to report earnings for its fourth quarter.

    • Barnes & Noble Education (NYSE:BNED) is likely to report quarterly loss at $0.16 per share on revenue of $252.67 million.

    • Aemetis (NASDAQ:AMTX) is likely to report quarterly loss at $0.25 per share on revenue of $71.44 million.

    • FuelCell Energy (NASDAQ:FCEL) is likely to report quarterly loss at $0.07 per share on revenue of $28.11 million.

    • Hut 8 Mining (NASDAQ:HUT) is projected to report quarterly loss at $0.14 per share on revenue of $25.87 million.

    • DarioHealth (NASDAQ:DRIO) is estimated to report quarterly loss at $0.65 per share on revenue of $6.29 million.

    • Aldeyra Therapeutics (NASDAQ:ALDX) is projected to report earnings for its fourth quarter.

    • Precision BioSciences (NASDAQ:DTIL) is estimated to report quarterly loss at $0.21 per share on revenue of $6.81 million.

    • Eltek (NASDAQ:ELTK) is likely to report earnings for its fourth quarter.

    • Lifetime Brands (NASDAQ:LCUT) is projected to report quarterly earnings at $0.24 per share on revenue of $201.86 million.

    • Akebia Therapeutics (NASDAQ:AKBA) is likely to report quarterly loss at $0.14 per share on revenue of $48.35 million.

    • Katapult Holdings (NASDAQ:KPLT) is projected to report quarterly earnings at $0.00 per share on revenue of $47.93 million.

    • Home Point Capital (NASDAQ:HMPT) is projected to report quarterly loss at $0.20 per share on revenue of $52.36 million.

    • Distribution Solutions (NASDAQ:DSGR) is likely to report quarterly earnings at $0.45 per share on revenue of $322.80 million.

    • Harvard Bioscience (NASDAQ:HBIO) is likely to report quarterly earnings at $0.03 per share on revenue of $30.33 million.

    • ProShares UltraShort Russell2000 (NYSE:TWM) is projected to report quarterly earnings at $0.04 per share on revenue of $500.69 million.

    • Overseas Shipholding Gr (NYSE:OSG) is expected to report earnings for its fourth quarter.

    • Docebo (NASDAQ:DCBO) is expected to report quarterly earnings at $0.02 per share on revenue of $39.40 million.

    • 22nd Century Group (NASDAQ:XXII) is likely to report quarterly loss at $0.06 per share on revenue of $20.57 million.

    • JD.com (NASDAQ:JD) is projected to report quarterly earnings at $0.51 per share on revenue of $42.96 billion.

    • Methode Electronics (NYSE:MEI) is expected to report quarterly earnings at $0.73 per share on revenue of $293.66 million.

    • Evogene (NASDAQ:EVGN) is likely to report quarterly loss at $0.20 per share on revenue of $420 thousand.

    • Duluth Holdings (NASDAQ:DLTH) is likely to report quarterly earnings at $0.65 per share on revenue of $277.65 million.

    • Global Business Travel (NYSE:GBTG) is projected to report quarterly loss at $0.15 per share on revenue of $507.06 million.

    • Solo Brands (NYSE:DTC) is estimated to report earnings for its fourth quarter.

    • Build-A-Bear Workshop (NYSE:BBW) is expected to report earnings for its fourth quarter.

    • BioXcel Therapeutics (NASDAQ:BTAI) is likely to report quarterly loss at $1.45 per share on revenue of $1.25 million.

    • Toro (NYSE:TTC) is projected to report quarterly earnings at $0.96 per share on revenue of $1.15 billion.

    • Global Indemnity Group (NYSE:GBLI) is projected to report quarterly earnings at $0.75 per share on revenue of $143.00 million.

    • Wheels Up Experience (NYSE:UP) is expected to report quarterly loss at $0.31 per share on revenue of $400.68 million.

    • Holley (NYSE:HLLY) is expected to report quarterly loss at $0.09 per share on revenue of $155.67 million.

    • John Wiley & Sons (NYSE:WLY) is projected to report quarterly earnings at $0.91 per share on revenue of $519.90 million.

    • Arrival (NASDAQ:ARVL) is expected to report earnings for its fourth quarter.

    • PowerFleet (NASDAQ:PWFL) is likely to report quarterly loss at $0.04 per share on revenue of $34.53 million.

    • Paysafe (NYSE:PSFE) is projected to report quarterly earnings at $0.05 per share on revenue of $375.25 million.

    • Village Farms Intl (NASDAQ:VFF) is estimated to report quarterly loss at $0.09 per share on revenue of $70.75 million.

    • Vital Farms (NASDAQ:VITL) is likely to report quarterly earnings at $0.04 per share on revenue of $100.29 million.

    • CareMax (NASDAQ:CMAX) is estimated to report quarterly loss at $0.05 per share on revenue of $149.38 million.

    • ANI Pharmaceuticals (NASDAQ:ANIP) is estimated to report quarterly earnings at $0.68 per share on revenue of $85.32 million.

    • BJ's Wholesale Club (NYSE:BJ) is projected to report quarterly earnings at $0.85 per share on revenue of $4.81 billion.

    • Angel Oak Mortgage (NYSE:AOMR) is estimated to report quarterly earnings at $0.31 per share on revenue of $13.73 million.

    • Arhaus (NASDAQ:ARHS) is estimated to report quarterly earnings at $0.20 per share on revenue of $348.25 million.

    • Townsquare Media (NYSE:TSQ) is projected to report quarterly earnings at $0.49 per share on revenue of $117.83 million.

    • Babylon Holdings (NYSE:BBLN) is expected to report quarterly loss at $4.42 per share on revenue of $290.38 million.

    • Broadwind (NASDAQ:BWEN) is likely to report quarterly loss at $0.15 per share on revenue of $42.70 million.

    • eMagin (AMEX:EMAN) is projected to report earnings for its fourth quarter.

    • Nano X Imaging (NASDAQ:NNOX) is estimated to report earnings for its fourth quarter.

    • AcuityAds Holdings (NASDAQ:ATY) is likely to report earnings for its fourth quarter.

    • European Wax Center (NASDAQ:EWCZ) is estimated to report earnings for its fourth quarter.

    • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its fourth quarter.

    • Genesco (NYSE:GCO) is projected to report quarterly earnings at $0.58 per share on revenue of $534.00 million.

    • Central Puerto (NYSE:CEPU) is expected to report earnings for its fourth quarter.

    Companies Reporting After The Bell

    • Frequency Electronics (NASDAQ:FEIM) is estimated to report earnings for its third quarter.

    • Regulus Therapeutics (NASDAQ:RGLS) is estimated to report earnings for its fourth quarter.

    • Entravision Comms (NYSE:EVC) is expected to report quarterly earnings at $0.19 per share on revenue of $261.45 million.

    • Molecular Partners (NASDAQ:MOLN) is estimated to report earnings for its Fiscal Year 2022.

    • Amplify Energy (NYSE:AMPY) is expected to report earnings for its fourth quarter.

    • Safeguard Scientifics (NASDAQ:SFE) is expected to report earnings for its fourth quarter.

    • Research Frontiers (NASDAQ:REFR) is expected to report earnings for its fourth quarter.

    • Hamilton Beach Brands (NYSE:HBB) is likely to report quarterly earnings at $0.97 per share on revenue of $202.60 million.

    • Cango (NYSE:CANG) is expected to report quarterly earnings at $0.04 per share on revenue of $72.24 million.

    • Helius Medical Tech (NASDAQ:HSDT) is expected to report quarterly loss at $0.13 per share on revenue of $260 thousand.

    • Douglas Elliman (NYSE:DOUG) is likely to report quarterly loss at $0.04 per share on revenue of $262.80 million.

    • Alto Ingredients (NASDAQ:ALTO) is likely to report quarterly loss at $0.06 per share on revenue of $342.43 million.

    • Inuvo (AMEX:INUV) is expected to report quarterly loss at $0.02 per share on revenue of $18.48 million.

    • AgileThought (NASDAQ:AGIL) is estimated to report quarterly loss at $0.16 per share on revenue of $42.25 million.

    • Tenon Medical (NASDAQ:TNON) is projected to report quarterly loss at $0.81 per share on revenue of $420 thousand.

    • DallasNews (NASDAQ:DALN) is estimated to report earnings for its fourth quarter.

    • Smith Micro Software (NASDAQ:SMSI) is estimated to report quarterly loss at $0.08 per share on revenue of $11.46 million.

    • iPath Series B Carbon Exchange-Traded Notes (NYSE:GRN) is projected to report quarterly loss at $0.01 per share on revenue of $20.22 million.

    • Oncternal Therapeutics (NASDAQ:ONCT) is expected to report quarterly loss at $0.21 per share on revenue of $330 thousand.

    • The One Group Hospitality (NASDAQ:STKS) is projected to report quarterly earnings at $0.16 per share on revenue of $89.73 million.

    • Oracle (NYSE:ORCL) is expected to report quarterly earnings at $1.20 per share on revenue of $12.42 billion.

    • Gritstone Bio (NASDAQ:GRTS) is expected to report quarterly loss at $0.34 per share on revenue of $2.90 million.

    • Aligos Therapeutics (NASDAQ:ALGS) is estimated to report quarterly loss at $0.47 per share on revenue of $1.72 million.

    • Guild Holdings (NYSE:GHLD) is likely to report quarterly earnings at $0.16 per share on revenue of $154.92 million.

    • aTyr Pharma (NASDAQ:LIFE) is expected to report quarterly loss at $0.48 per share on revenue of $420 thousand.

    • Lineage Cell Therapeutics (AMEX:LCTX) is projected to report quarterly loss at $0.04 per share on revenue of $2.57 million.

    • ETF Series Solutions Blue Horizon BNE ETF (NYSE:BNE) is expected to report earnings for its fourth quarter.

    • Wheaton Precious Metals (NYSE:WPM) is expected to report earnings for its fourth quarter.

    • Aqua Metals (NASDAQ:AQMS) is projected to report earnings for its fourth quarter.

    • Comtech Telecom (NASDAQ:CMTL) is expected to report quarterly loss at $0.09 per share on revenue of $133.30 million.

    • Bionano Genomics (NASDAQ:BNGO) is projected to report quarterly loss at $0.11 per share on revenue of $8.05 million.

    • Aterian (NASDAQ:ATER) is estimated to report quarterly loss at $0.27 per share on revenue of $51.81 million.

    • 360 DigiTech (NASDAQ:QFIN) is likely to report quarterly earnings at $0.49 per share on revenue of $607.98 million.

    • Aware (NASDAQ:AWRE) is likely to report quarterly loss at $0.14 per share on revenue of $3.10 million.

    • Ring Energy (AMEX:REI) is estimated to report quarterly earnings at $0.22 per share on revenue of $109.00 million.

    • Archer Aviation (NYSE:ACHR) is expected to report earnings for its fourth quarter.

    • Hydrofarm Holdings Group (NASDAQ:HYFM) is expected to report quarterly loss at $0.45 per share on revenue of $48.37 million.

    • NN (NASDAQ:NNBR) is projected to report quarterly loss at $0.02 per share on revenue of $123.30 million.

    • Alta Equipment Group (NYSE:ALTG) is expected to report earnings for its fourth quarter.

    • CytoSorbents (NASDAQ:CTSO) is likely to report quarterly loss at $0.17 per share on revenue of $8.72 million.

    • Clearside Biomedical (NASDAQ:CLSD) is estimated to report quarterly loss at $0.13 per share on revenue of $100 thousand.

    • Energous (NASDAQ:WATT) is expected to report quarterly loss at $0.07 per share on revenue of $200 thousand.

    • Limoneira (NASDAQ:LMNR) is estimated to report quarterly loss at $0.35 per share on revenue of $37.19 million.

    • Iridex (NASDAQ:IRIX) is projected to report quarterly loss at $0.11 per share on revenue of $15.16 million.

    • Concrete Pumping Holdings (NASDAQ:BBCP) is estimated to report quarterly earnings at $0.05 per share on revenue of $94.67 million.

    • Mission Produce (NASDAQ:AVO) is likely to report quarterly earnings at $0.01 per share on revenue of $207.12 million.

    • AudioEye (NASDAQ:AEYE) is expected to report quarterly loss at $0.22 per share on revenue of $7.75 million.

    • Gap (NYSE:GPS) is projected to report quarterly loss at $0.47 per share on revenue of $4.36 billion.

    • Information Servs Gr (NASDAQ:III) is estimated to report quarterly earnings at $0.11 per share on revenue of $71.22 million.

    • Velocity Financial (NYSE:VEL) is projected to report quarterly earnings at $0.29 per share on revenue of $27.70 million.

    • Adecoagro (NYSE:AGRO) is expected to report quarterly earnings at $0.20 per share on revenue of $238.00 million.

    • PlayAGS (NYSE:AGS) is likely to report quarterly loss at $0.07 per share on revenue of $78.12 million.

    • HireRight Holdings (NYSE:HRT) is likely to report quarterly earnings at $0.21 per share on revenue of $170.40 million.

    • AvePoint (NASDAQ:AVPT) is projected to report quarterly earnings at $0.01 per share on revenue of $64.02 million.

    • DocuSign (NASDAQ:DOCU) is projected to report quarterly earnings at $0.52 per share on revenue of $632.22 million.

    • Willdan Group (NASDAQ:WLDN) is projected to report quarterly earnings at $0.41 per share on revenue of $64.84 million.

    • Joint (NASDAQ:JYNT) is projected to report quarterly earnings at $0.07 per share on revenue of $27.31 million.

    • El Pollo Loco Holdings (NASDAQ:LOCO) is likely to report quarterly earnings at $0.14 per share on revenue of $115.35 million.

    • Bowman Consulting Group (NASDAQ:BWMN) is projected to report quarterly earnings at $0.15 per share on revenue of $69.86 million.

    • The Oncology Institute (NASDAQ:TOI) is estimated to report quarterly loss at $0.18 per share on revenue of $64.75 million.

    • Heritage Glb (NASDAQ:HGBL) is likely to report quarterly earnings at $0.04 per share on revenue of $10.95 million.

    • HCI Group (NYSE:HCI) is likely to report quarterly loss at $0.51 per share on revenue of $120.40 million.

    • Logan Ridge Finance (NASDAQ:LRFC) is expected to report quarterly earnings at $0.06 per share on revenue of $4.10 million.

    • Quanex Building Prods (NYSE:NX) is likely to report quarterly earnings at $0.32 per share on revenue of $269.50 million.

    • PLAYSTUDIOS (NASDAQ:MYPS) is likely to report earnings for its fourth quarter.

    • Smith & Wesson Brands (NASDAQ:SWBI) is projected to report quarterly earnings at $0.30 per share on revenue of $135.79 million.

    • Zumiez (NASDAQ:ZUMZ) is expected to report quarterly earnings at $0.03 per share on revenue of $222.00 million.

    • SpringBig Holdings (NASDAQ:SBIG) is expected to report quarterly loss at $0.12 per share on revenue of $7.40 million.

    • Rain Oncology (NASDAQ:RAIN) is estimated to report earnings for its fourth quarter.

    • a.k.a. Brands Holding (NYSE:AKA) is estimated to report quarterly earnings at $0.01 per share on revenue of $161.83 million.

    • Allbirds (NASDAQ:BIRD) is likely to report quarterly loss at $0.12 per share on revenue of $97.14 million.

    • Airgain (NASDAQ:AIRG) is projected to report quarterly earnings at $0.06 per share on revenue of $20.46 million.

    • Vail Resorts (NYSE:MTN) is projected to report quarterly earnings at $9.44 per share on revenue of $1.31 billion.

    • AppHarvest (NASDAQ:APPH) is projected to report quarterly loss at $0.35 per share on revenue of $4.20 million.

    • Jakks Pacific (NASDAQ:JAKK) is estimated to report quarterly loss at $1.37 per share on revenue of $95.00 million.

    • Ulta Beauty (NASDAQ:ULTA) is expected to report quarterly earnings at $6.50 per share on revenue of $2.48 billion.

    • Tilly's (NYSE:TLYS) is projected to report quarterly loss at $0.01 per share on revenue of $150.30 million.

    • Bakkt Hldgs (NYSE:BKKT) is likely to report quarterly loss at $0.18 per share on revenue of $16.48 million.

    • Portman Ridge Finance (NASDAQ:PTMN) is likely to report earnings for its fourth quarter.

    • HashiCorp (NASDAQ:HCP) is estimated to report quarterly loss at $0.19 per share on revenue of $129.06 million.

    • American Outdoor Brands (NASDAQ:AOUT) is projected to report quarterly earnings at $0.05 per share on revenue of $48.21 million.

    • Gevo (NASDAQ:GEVO) is likely to report quarterly loss at $0.05 per share on revenue of $2.42 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHR
    $ACOR
    $AEYE
    $AGIL

    CompanyDatePrice TargetRatingAnalyst
    Oracle Corporation
    $ORCL
    2/9/2026Buy → Hold
    Melius
    Oracle Corporation
    $ORCL
    2/9/2026$180.00Neutral → Buy
    DA Davidson
    Allbirds Inc.
    $BIRD
    2/4/2026Buy → Hold
    Maxim Group
    Oracle Corporation
    $ORCL
    2/4/2026$270.00 → $205.00Outperform
    BMO Capital Markets
    Hut 8 Corp.
    $HUT
    2/2/2026$80.00Buy
    H.C. Wainwright
    BJ's Wholesale Club Holdings Inc.
    $BJ
    1/28/2026$90.00Buy → Hold
    Jefferies
    Molecular Partners AG
    $MOLN
    1/27/2026$13.00Buy
    H.C. Wainwright
    Lifetime Brands Inc.
    $LCUT
    1/26/2026$3.50Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Hounsell Bruce Kenneth

    3 - Heritage Global Inc. (0000849145) (Issuer)

    2/9/26 4:34:24 PM ET
    $HGBL
    Real Estate

    Baes Nicholas decreased direct ownership by 5% to 101,023 units (SEC Form 5)

    5 - Bakkt, Inc. (0001820302) (Issuer)

    2/6/26 7:02:42 PM ET
    $BKKT
    Finance: Consumer Services
    Finance

    Chief Legal Officer Brown Brian Michael covered exercise/tax liability with 322 shares, decreasing direct ownership by 0.05% to 644,107 units (SEC Form 4)

    4 - AvePoint, Inc. (0001777921) (Issuer)

    2/6/26 4:05:10 PM ET
    $AVPT
    Computer Software: Prepackaged Software
    Technology

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Oracle AI Agents Help Supply Chain Leaders Boost Efficiency and Strengthen Resiliency

    New AI agents embedded in Oracle Fusion Cloud Applications help supply chain professionals act faster, reduce risk, and improve operational performance MUMBAI, Feb. 10, 2026 /PRNewswire/ -- Oracle AI World Tour -- Oracle today announced new AI agents within Oracle Fusion Cloud Applications to help supply chain leaders accelerate decision-making and drive greater efficiency across planning, procurement, manufacturing, maintenance, and logistics. Built using Oracle AI Agent Studio for Fusion Applications, the new AI agents are embedded within supply chain processes to help leaders unlock productivity gains and enhance business performance by automating end-to-end workflows and delivering insig

    2/10/26 3:01:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Helps Organizations Enhance Process Manufacturing

    New recipe and materials management, batch execution, and compliance capabilities in Oracle Fusion Cloud SCM help customers improve control, enhance quality, and lower risk MUMBAI, India, Feb. 10, 2026 /PRNewswire/ -- Oracle AI World -- Oracle today announced new capabilities in Oracle Fusion Cloud Supply Chain & Manufacturing (SCM) to help organizations manage the unique requirements of process manufacturing. The latest innovations help organizations that produce goods by mixing or blending ingredients improve real-time production visibility and meet regulatory requirements by connecting formulas, recipes, materials, and batch execution in a unified cloud solution.

    2/10/26 3:01:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle AI Agents Help Marketing, Sales, and Service Leaders Enhance Customer Experiences

    New role-based AI agents embedded in Oracle Fusion Cloud Applications transform slow and reactive sales, marketing, and service processes into revenue driving opportunities MUMBAI, Feb. 10, 2026 /PRNewswire/ -- Oracle AI World Tour -- Oracle today announced new role-based AI agents within Oracle Fusion Cloud Applications to help organizations deliver intelligent customer experiences (CX) at scale. Built using Oracle AI Agent Studio for Fusion Applications, the new AI agents are embedded within marketing, sales, and service processes to help CX leaders drive productivity gains and enhance business performance by analyzing unified data, automating processes, and delivering predictive insights

    2/10/26 3:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VAFSEO issued to AKEBIA THERAPEUTICS INC

    Submission status for AKEBIA THERAPEUTICS INC's drug VAFSEO (ORIG-1) with active ingredient VADADUSTAT has changed to 'Approval' on 03/27/2024. Application Category: NDA, Application Number: 215192, Application Classification: Type 1 - New Molecular Entity

    3/28/24 10:46:38 AM ET
    $AKBA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IGALMI issued to BIOXCEL THERAPEUTICS, INC.

    Submission status for BIOXCEL THERAPEUTICS, INC.'s drug IGALMI (ORIG-1) with active ingredient DEXMEDETOMIDINE has changed to 'Approval' on 04/05/2022. Application Category: NDA, Application Number: 215390, Application Classification: Type 3 - New Dosage Form

    4/6/22 2:18:32 PM ET
    $BTAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 18, 2022 - FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States

    For Immediate Release: February 18, 2022 Today, the U.S. Food and Drug Administration is alerting the public that several categories of FDA-regulated products purchased from Jan. 1, 2021, through the present from Family Dollar stores in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee may be unsafe for consumers to use. The impacted products originated from the company’s distribution facility in

    2/18/22 8:06:10 PM ET
    $ARVL
    Auto Manufacturing
    Consumer Discretionary

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Finance Op and Tech Schatz Scott bought $6,478 worth of shares (980 units at $6.61), increasing direct ownership by 2% to 58,051 units (SEC Form 4)

    4 - Townsquare Media, Inc. (0001499832) (Issuer)

    2/4/26 4:51:27 PM ET
    $TSQ
    Broadcasting
    Consumer Discretionary

    Chief Financial Officer Dizon Romeo R bought $3,450 worth of shares (2,500 units at $1.38), increasing direct ownership by 2% to 115,190 units (SEC Form 4)

    4 - IRIDEX CORP (0001006045) (Issuer)

    2/3/26 6:21:19 PM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Botha Roelof bought $4,949,975 worth of shares (260,525 units at $19.00), converted options into 12,000,124 shares and returned 12,000,124 shares to the company (SEC Form 4)

    4 - Ethos Technologies Inc. (0001788451) (Issuer)

    2/2/26 6:36:37 PM ET
    $LIFE
    Specialty Insurers
    Finance

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by BioXcel Therapeutics Inc.

    SCHEDULE 13G/A - BioXcel Therapeutics, Inc. (0001720893) (Subject)

    2/9/26 4:13:17 PM ET
    $BTAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Harvard Bioscience Inc.

    424B3 - HARVARD BIOSCIENCE INC (0001123494) (Filer)

    2/9/26 4:03:05 PM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 6-K filed by Eltek Ltd.

    6-K - ELTEK LTD (0001024672) (Filer)

    2/9/26 7:35:31 AM ET
    $ELTK
    Electrical Products
    Technology

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oracle downgraded by Melius

    Melius downgraded Oracle from Buy to Hold

    2/9/26 9:24:14 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle upgraded by DA Davidson with a new price target

    DA Davidson upgraded Oracle from Neutral to Buy and set a new price target of $180.00

    2/9/26 6:56:02 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Allbirds downgraded by Maxim Group

    Maxim Group downgraded Allbirds from Buy to Hold

    2/4/26 8:06:33 AM ET
    $BIRD
    Apparel
    Consumer Discretionary

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Financials

    Live finance-specific insights

    View All

    Octave Specialty Group to Release Fourth Quarter 2025 Results on February 23, 2026

    Conference Call Scheduled for February 24, 2026 Octave Specialty Group, Inc. (NYSE:OSG), a global specialty insurance firm, will release fourth quarter 2025 results on February 23, 2026, following the close of the market. Conference Call On February 24, 2026, at 8:30am (ET), Claude LeBlanc, President and Chief Executive Officer, and David Trick, Executive Vice President and Chief Financial Officer, will discuss fourth quarter 2025 results during a live conference call. A live audio webcast of the call will be available through the Investor Relations section of Octave's website, www.octavegroup.com. Participants may also listen via telephone by dialing (877) 407-9716 (Domestic) or (201

    2/9/26 8:30:00 AM ET
    $OSG
    Property-Casualty Insurers
    Finance

    JAKKS Pacific, Inc. Announces Fourth Quarter and Full-Year 2025 Earnings Call

    SANTA MONICA, Calif., Feb. 06, 2026 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (NASDAQ:JAKK) will announce its fourth quarter and full-year 2025 financial results on Thursday, February 19, 2026 after the close of the stock market. The Company invites analysts, investors and media to listen to a teleconference scheduled for 5:00 p.m. ET / 2:00 p.m. PT on February 19, 2026 to discuss the results, and potentially future plans and prospects. A live webcast of the call will be available on the "Investor Relations" page of the Company's website at www.jakks.com/investors. To access the call by phone, please go to this link (4Q25 Registration link), and you will be provided with dial-in details. To

    2/6/26 9:00:00 AM ET
    $JAKK
    Recreational Games/Products/Toys
    Consumer Discretionary

    Wheaton Precious Metals Announces Leadership Evolution: Haytham Hodaly Appointed President and CEO, Randy Smallwood to Become Chair of the Board

    VANCOUVER, BC , Feb. 5, 2026 /PRNewswire/ - Wheaton Precious Metals™ Corp. ("Wheaton" or the "Company") today announced, as part of the Company's strategic succession planning, Haytham Hodaly, currently President, will succeed Randy Smallwood as Wheaton's Chief Executive Officer ("CEO"), reflecting an ongoing leadership evolution to support the next phase in the Company's growth trajectory. After more than 15 years of leading the business he co-founded, Mr. Smallwood will step down as CEO and assume the role of non-executive Chair of the Board of Directors, effective March 31, 2026. As Board Chair, Mr. Smallwood's ongoing involvement will provide leadership continuity and alignment to the C

    2/5/26 5:00:00 PM ET
    $WPM
    Precious Metals
    Basic Materials

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Leadership Updates

    Live Leadership Updates

    View All

    Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board

    Appointments Strengthen Scientific Leadership and Support the Acceleration of ChemPass AI™ for Drug and Ag-Chemical Discovery REHOVOT, Israel, Feb. 9, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a leading computational chemistry company focused on the AI-driven discovery and design of novel small molecules for the pharmaceutical and agricultural industries, today announced the appointment of Prof. John J. Irwin of the University of California, San Francisco (UCSF), and Prof. Dan T. Major of Bar-Ilan University (BIU) to its scientific advisory board (SAB). The

    2/9/26 8:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    Cango Inc. Completes Bitcoin Sale to Strengthen Financial Position and Advance AI Transformation

    DALLAS, Feb. 9, 2026 /PRNewswire/ -- Cango Inc. (NYSE:CANG) ("Cango" or the "Company"), a leading Bitcoin miner leveraging its global operations to develop an integrated energy and AI compute platform, today announced that, based on a comprehensive assessment of current market conditions and upon approval of the Company's Board of Directors, it completed the sale of 4,451 Bitcoin on the open market during the past weekend, which were settled directly in USDT for aggregate net proceeds of approximately US$305 million in equivalent value. The full amount of the USDT proceeds has been utilized to partially repay a Bitcoin-collateralized loan.

    2/9/26 6:26:00 AM ET
    $CANG
    Computer Software: Prepackaged Software
    Technology

    Inuvo Appoints Rob Buchner as Chairman and Chief Executive Officer

    LITTLE ROCK, Ark., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE:INUV), a leading provider of artificial intelligence-driven data and advertising technology solutions, today announced the appointment of Rob Buchner as Chairman of the Board and Chief Executive Officer, effective February 1, 2026. Throughout 2025, Buchner worked closely within Inuvo in an advisory, board, and executive capacity. This experience has provided a comprehensive understanding of the company's existing markets, strategy, technology, and growth opportunities. Since joining the executive team as Chief Operating Officer in October of 2025, he has led a comprehensive review of talent, operations, product devel

    1/28/26 4:15:00 PM ET
    $INUV
    Advertising
    Consumer Discretionary

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Logan Ridge Finance Corporation

    SC 13D/A - Logan Ridge Finance Corp. (0001571329) (Subject)

    12/17/24 5:19:31 PM ET
    $LRFC
    Finance: Consumer Services
    Finance

    SEC Form SC 13G filed by DarioHealth Corp.

    SC 13G - DarioHealth Corp. (0001533998) (Subject)

    12/13/24 4:05:12 PM ET
    $DRIO
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by Hamilton Beach Brands Holding Company

    SC 13D/A - Hamilton Beach Brands Holding Co (0001709164) (Subject)

    12/10/24 5:37:18 PM ET
    $HBB
    Home Furnishings
    Consumer Discretionary